Concentrix (CNXC) EVP Legal Jane Fogarty logs RSU vesting and tax share sale

Rhea-AI Filing Summary

Concentrix Corp executive Jane Fogarty reported routine equity compensation activity. On January 28, 2026, she acquired 220 shares of common stock at $0 per share upon vesting of performance-based restricted stock units granted under the 2020 Stock Incentive Plan. On the same date, 79 shares were disposed of at $36.32 per share, typically reflecting shares withheld to cover taxes, leaving her with 31,593 shares of Concentrix common stock held directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fogarty Jane

(Last) (First) (Middle)

39899 BALENTINE DRIVE

SUITE 235

(Street)

NEWARK CA 94560

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Concentrix Corp [ CNXC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Legal

3. Date of Earliest Transaction (Month/Day/Year)
01/28/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/28/2026		A		220(1)	A	$0	31,672	D
Common Stock	01/28/2026		F		79	D	$36.32	31,593	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares issued upon the vesting of restricted stock units awarded under the 2020 Stock Incentive Plan on January 27, 2023, subject to the satisfaction of performance metrics measured over a three-year period ending November 30, 2025.

Remarks:

	/s/ Andrew A. Farwig, Attorney-in-Fact	01/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did CNXC EVP Legal Jane Fogarty report on this Form 4?

Jane Fogarty reported two transactions in Concentrix (CNXC) common stock. She received 220 shares at $0 per share from vested performance-based restricted stock units and had 79 shares disposed of at $36.32 per share, leaving her with 31,593 directly held shares.

How many Concentrix (CNXC) shares does Jane Fogarty own after the reported Form 4 trades?

Following the reported transactions, Jane Fogarty directly owns 31,593 Concentrix (CNXC) common shares. This figure reflects the net result after 220 shares were issued from restricted stock unit vesting and 79 shares were disposed of on January 28, 2026.

What was the nature of the 220 Concentrix (CNXC) shares acquired by Jane Fogarty?

The 220 Concentrix (CNXC) shares were issued at $0 per share upon vesting of restricted stock units. These units were granted under the 2020 Stock Incentive Plan and were subject to performance metrics measured over a three-year period ending November 30, 2025.

Why were 79 Concentrix (CNXC) shares disposed of in Jane Fogarty’s Form 4 filing?

The Form 4 shows 79 Concentrix (CNXC) shares disposed of at $36.32 per share with code “F.” This transaction code commonly indicates shares withheld to satisfy tax obligations related to equity awards, consistent with the same date as the restricted stock unit vesting.

What performance period applied to Jane Fogarty’s Concentrix (CNXC) restricted stock units?

The restricted stock units that vested into 220 Concentrix (CNXC) shares were granted January 27, 2023. They were subject to performance metrics measured over a three-year period ending November 30, 2025, under the company’s 2020 Stock Incentive Plan.

Is this Concentrix (CNXC) Form 4 filing a major insider sale or a routine equity vesting?

This Form 4 reflects routine equity compensation activity rather than a large open-market sale. It shows 220 shares received from performance-based restricted stock unit vesting and 79 shares disposed of, likely for taxes, with total direct holdings moving to 31,593 shares.